Clinical Trials on Gastrin-Producing Neuroendocrine Tumor in Norway
Total 95 results
-
National Cancer Institute (NCI)Active, not recruitingNeuroendocrine Tumor | Neuroendocrine Neoplasm | Colorectal Neuroendocrine Tumor G1 | Gastric Neuroendocrine Tumor G1 | Neuroendocrine Tumor G2United States
-
National Cancer Institute (NCI)Active, not recruitingCarcinoid Tumor | Functioning Pancreatic Neuroendocrine Tumor | Intermediate Grade Lung Neuroendocrine Neoplasm | Locally Advanced Pancreatic Neuroendocrine Tumor | Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm | Low Grade Lung Neuroendocrine Neoplasm | Metastatic Digestive... and other conditionsUnited States
-
Trio Medicines Ltd.Norwegian University of Science and TechnologyTerminatedChronic Atrophic Gastritis | Hypergastrinemia | Type I Gastric CarcinoidsNorway
-
Oslo University HospitalUniversity Hospital of North Norway; Haukeland University Hospital; St. Olavs...RecruitingPancreatic Neuroendocrine Tumors, WHO Grade I-IINorway
-
IpsenCompletedNeuroendocrine Tumour With Carcinoid SymptomsDenmark, Norway, Sweden
-
Haukeland University HospitalUllevaal University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark and other collaboratorsCompletedNeuroendocrine CarcinomaNorway
-
Sykehuset i Vestfold HFOslo University Hospital; Helse Sor-Ost; University of Geneva, Switzerland; Car...RecruitingQuality of Life | Small Bowel Cancer | Lymph Node Metastases | Small Bowel Carcinoid Tumor | Tumor MetastasisNorway
-
Ultimovacs ASAOslo University HospitalActive, not recruiting
-
Haukeland University HospitalHoffmann-La Roche; Norwegian Cancer SocietyCompleted
-
National Cancer Institute (NCI)CompletedLocally Advanced Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Pancreatic Vipoma | Pancreatic Gastrinoma | Advanced Pancreatic Neuroendocrine TumorUnited States, Canada
-
Oslo University HospitalCompletedEarly Complications After Axillary and Inguinal Lymph Node Dissection in Stage III Melanoma PatientsMelanoma | ComplicationNorway
-
Oslo University HospitalCompleted
-
Steinar AamdalTerminatedMetastatic Malignant MelanomaNorway
-
Oslo University HospitalCompleted
-
Haukeland University HospitalBerGenBio ASAActive, not recruiting
-
Haukeland University HospitalNorwegian Cancer Society; The Norwegian Melanoma GroupTerminatedMetastatic Malignant Melanoma | Unresectable Malignant MelanomaNorway
-
HutchmedActive, not recruitingNeuroendocrine Tumours | Neuroendocrine Tumour of the Lung | Small Intestinal NETSpain, France, United States, United Kingdom, Norway, Germany, Italy
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsFinland, Norway, Sweden, Denmark, Latvia, Lithuania, Estonia
-
University Hospital of North NorwayUniversity of Tromso; The Research Council of NorwayCompleted
-
PfizerCompletedWell-differentiated Pancreatic Neuroendocrine TumorUnited States, China, Czechia, India, Japan, South Africa, Slovakia, France, Norway, Romania, Australia, Belgium, Hungary, Italy, Spain
-
Oslo University HospitalActive, not recruitingMalignant MelanomaNorway
-
GlaxoSmithKlineTerminatedMelanomaNorway, Argentina, Greece
-
Clavis PharmaCompletedMalignant MelanomaUnited States, Sweden, Norway
-
University Hospital of North NorwayCompletedMelanoma (Skin) | Actinic Keratoses | Non-melanoma Skin CancerNorway
-
Clavis PharmaCompletedNeoplasm Metastasis | Malignant MelanomaUnited States, Norway, Sweden
-
Haukeland University HospitalCompleted
-
Targovax OyCompletedAdvanced or Unresectable Melanoma Progressing After PD1 BlockadeUnited States, Norway
-
Novartis PharmaceuticalsCompletedSymptomatic Refractory Resistant Carcinoid DiseaseUnited Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
-
Lytix Biopharma ASLaboratory Corporation of America; OWLActive, not recruitingAdvanced MelanomaUnited States, Spain, France, Norway
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruitingMelanoma Stage IvAustralia, Norway
-
Haukeland University HospitalActive, not recruiting
-
Novartis PharmaceuticalsCompletedAcromegaly | Carcinoid TumorGermany, Belgium, Canada, Netherlands, United States, Norway
-
Novartis PharmaceuticalsTerminatedUveal MelanomaUnited States, Australia, France, Netherlands, Spain, Norway
-
European Organisation for Research and Treatment...CompletedMelanoma (Skin)France, Switzerland, Norway, Belgium, United Kingdom, Germany, Austria, Portugal, Italy
-
Bristol-Myers SquibbCompletedMelanomaItaly, Netherlands, Russian Federation, Czechia, Hungary, Ireland, Norway, Spain, Switzerland, Austria, Germany, Denmark, France, Belgium, United Kingdom, United States
-
Bristol-Myers SquibbCompletedUnresectable Stage III or IV Malignant MelanomaUnited States, Peru, Norway, Italy, Sweden, Denmark, Israel
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingGastrinoma | Glucagonoma | Insulinoma | Pancreatic Polypeptide Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | Islet Cell CarcinomaUnited States
-
AstraZenecaCompletedMelanomaSweden, United States, Brazil, Czech Republic, France, Spain, United Kingdom, Germany, Norway, Hungary, Netherlands, Switzerland
-
PfizerCompletedMelanoma and Metastatic Colorectal CancerUnited States, Spain, France, Japan, Australia, Switzerland, Norway
-
Bristol-Myers SquibbMedarexCompletedMelanomaUnited States, Spain, Austria, Italy, Sweden, Russian Federation, Ukraine, Finland, Norway, Poland
-
European Organisation for Research and Treatment...TerminatedMetastatic Cancer | Melanoma (Skin)France, Norway, Belgium, Netherlands, United Kingdom, Austria, Czech Republic, Germany, Italy, Portugal, Switzerland
-
Bristol-Myers SquibbCompletedMelanomaCanada, Australia, Germany, Italy, Poland, France, Denmark, Argentina, Chile, Spain, Norway, Israel, Sweden, Mexico, Greece, Finland
-
Bristol-Myers SquibbCompletedMelanomaSouth Africa, United States, Spain, France, Italy, Belgium, Austria, Israel, Germany, Norway, Canada, Brazil, Poland, Denmark, Czech Republic, Russian Federation, Ukraine, Argentina
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Bristol-Myers SquibbMedarexCompletedMelanomaUnited States, Brazil, France, Italy, South Africa, United Kingdom, Argentina, Australia, Canada, Ireland, Israel, Russian Federation, Spain, Belgium, Germany, Portugal, Chile, Austria, Poland, Netherlands, Ukraine, Czech Republic, ... and more
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)Italy, France, Spain, Switzerland, United Kingdom, Belgium, Australia, Norway, Poland, Finland, Netherlands, Germany, Israel, Denmark, Serbia, Estonia, Portugal, Russian Federation
-
Genentech, Inc.Active, not recruitingMelanomaUnited States, Germany, Australia, Korea, Republic of, Canada, Norway
-
Bristol-Myers SquibbCompletedMelanomaAustralia, France, Italy, Poland, United Kingdom, United States, Spain, Belgium, Denmark, Germany, Norway, Switzerland, Argentina, Austria, Sweden, Czechia, Hungary, Netherlands, Mexico, Canada, Israel, South Africa
-
Bristol-Myers SquibbCompletedMelanomaAustralia, France, Italy, Belgium, Finland, Austria, Ireland, Sweden, Switzerland, United Kingdom, Germany, Norway
-
Merck Sharp & Dohme LLCTerminatedAdvanced/Metastatic MelanomaUnited States, Australia, Chile, France, Germany, Israel, Italy, Korea, Republic of, Norway, South Africa, Spain